CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 78 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $3,170,000 | +24.9% | 250,804 | -3.0% | 0.07% | -1.4% |
| Q3 2020 | $2,539,000 | -3.3% | 258,533 | -2.1% | 0.07% | -3.9% |
| Q2 2020 | $2,626,000 | +14.1% | 263,958 | +1.4% | 0.08% | -10.6% |
| Q1 2020 | $2,302,000 | +163.4% | 260,362 | +174.9% | 0.08% | +304.8% |
| Q4 2019 | $874,000 | +54.1% | 94,697 | -1.7% | 0.02% | +50.0% |
| Q3 2019 | $567,000 | -52.3% | 96,377 | -2.8% | 0.01% | -50.0% |
| Q2 2019 | $1,189,000 | – | 99,106 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| L1 Capital Pty Ltd | 1,149,120 | $14,559,000 | 2.72% |
| Corriente Advisors, LLC | 680,000 | $8,595,000 | 2.05% |
| ACUTA CAPITAL PARTNERS, LLC | 537,500 | $6,794,000 | 1.85% |
| INGALLS & SNYDER LLC | 1,362,203 | $17,218,000 | 0.85% |
| Kensington Investment Counsel, LLC | 75,533 | $955,000 | 0.79% |
| SPHERA FUNDS MANAGEMENT LTD. | 384,039 | $4,854,000 | 0.43% |
| Opaleye Management Inc. | 254,000 | $3,211,000 | 0.42% |
| RA Capital Management | 1,823,520 | $23,049,000 | 0.32% |
| Perceptive Advisors | 2,150,641 | $27,184,000 | 0.29% |
| Parkman Healthcare Partners LLC | 50,290 | $636,000 | 0.16% |